https://doi.org/10.4081/aiua.2020.4.371

Erectile dysfunction in common neurological conditions: A narrative review

Vol. 92 No. 4 (2020)
Submitted: May 19, 2020
Accepted: June 8, 2020
Published: December 21, 2020
Erectile dysfunction, Neurogenic, Neurologic disability, Management
Abstract Views: 2309
PDF: 1280
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

Mohamad Moussa
Urology Department, Zahraa Hospital, University Medical Center, Beirut, Lebanon.
Athanasios G. Papatsoris
2nd Department of Urology, School of Medicine, Sismanoglio Hospital, National and Kapodistrian University of Athens, Athens, Greece.
Mohamad Abou Chakra
mohamedabouchakra@hotmail.com
Department of Urology, Faculty of Medical Sciences, Lebanese University, Beirut, Lebanon.
Baraa Dabboucy
Department of Neurosurgery, Faculty of Medical Sciences, Lebanese University, Beirut, Lebanon.
Youssef Fares
Department of Neurosurgery, Neuroscience Research Center, Faculty of Medical Sciences, Lebanese University, Beirut, Lebanon.

Neurogenic erectile dysfunction (NED) can be defined as the inability to achieve or maintain an erection due to central or peripheral neurologic disease. Neurologic diseases can also affect the physical ability and psychological status of the patient. All these factors may lead to a primary or secondary NED. Medication history plays an important role since there are many drugs commonly used in neurologic patients that can lead to ED. The assessment of NED in these patients is generally evolving with the application of evoked potentials technology in the test of somatic and autonomic nerves, and functional magnetic resonance imaging. With the electrophysiological examinations, neurogenic causes can be determined. These tools allow to categorize neurologic lesion and assess the patient prognosis. The first-line treatment for NED is phosphodiesterase inhibitors. Second-line treatments include intracavernous and intraurethral vasoactive injections. Third-line treatments are penile prostheses. The efficacy and safety of each treatment modality depend on the specific neurologic condition. This review discusses the physiology, pathophysiology, diagnosis, and treatment of ED in multiple peripheral and central neurologic conditions, as well as for future research.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Citations

Crossref
Scopus
Google Scholar
Europe PMC
-Fabbri A, Aversa A, Isidori A. Erectile dysfunction: an overview. Hum Reprod Update. 1997;3(5):455‐466. DOI: https://doi.org/10.1093/humupd/3.5.455
-Yafi FA, Jenkins L, Albersen M, et al. Erectile dysfunction. Nat Rev Dis Primers. 2016;2:16003. DOI: https://doi.org/10.1038/nrdp.2016.3
-Pastuszak AW. Current Diagnosis and Management of Erectile Dysfunction. Curr Sex Health Rep. 2014;6(3):164‐176. DOI: https://doi.org/10.1007/s11930-014-0023-9
-Persu C, Cauni V, Gutue S, Albu ES, Jinga V, Geavlete P. Diagnosis and treatment of erectile dysfunction--a practical update. J Med Life. 2009;2(4):394‐400.
-Papagiannopoulos D, Khare N, Nehra A. Evaluation of young men with organic erectile dysfunction. Asian J Androl. 2015;17(1):11‐16. DOI: https://doi.org/10.4103/1008-682X.139253
-Glina S, Cohen DJ, Vieira M. Diagnosis of erectile dysfunction. Curr Opin Psychiatry. 2014;27(6):394‐399. DOI: https://doi.org/10.1097/YCO.0000000000000097
-Lasker GF, Maley JH, Kadowitz PJ. A Review of the Pathophysiology and Novel Treatments for Erectile Dysfunction. Adv Pharmacol Sci. 2010;2010:730861. DOI: https://doi.org/10.1155/2010/730861
-Heidelbaugh JJ. Management of erectile dysfunction. Am Fam Physician. 2010;81(3):305‐312.
-Fazio L, Brock G. Erectile dysfunction: management update. CMAJ. 2004;170(9):1429‐1437. DOI: https://doi.org/10.1503/cmaj.1020049
-Bertero EB, Antunes DL. Surgical Treatment of Erectile Dysfunction. Sex Med Rev. 2015;3(4):316‐327. DOI: https://doi.org/10.1002/smrj.60
-Bettocchi C, Palumbo F, Spilotros M, et al. Penile prostheses. Ther Adv Urol. 2010;2(1):35‐40. DOI: https://doi.org/10.1177/1756287209359174
- Calabrò RS, Gervasi G, Naro A, de Luca R, Marullo M, Bramanti P. Erectile Dysfunction in Individuals with Neurologic Disability: A Hospital-based Cross-sectional Study. Innov Clin Neurosci. 2016;13(1-2):10‐14.
- Dean RC, Lue TF. Physiology of penile erection and pathophysiology of erectile dysfunction. Urol Clin North Am. 2005;32(4):379‐v. DOI: https://doi.org/10.1016/j.ucl.2005.08.007
- Giuliano F, Rampin O. Neural control of erection. Physiol Behav. 2004;83(2):189‐201. DOI: https://doi.org/10.1016/j.physbeh.2004.08.014
- Yang CC, Jiang X. Clinical autonomic neurophysiology and the male sexual response: an overview. J Sex Med. 2009;6 Suppl 3(Suppl 3):221‐228. DOI: https://doi.org/10.1111/j.1743-6109.2008.01180.x
- Giuliano F, Rampin O, Brown K, Courtois F, Benoit G, Jardin A. Stimulation of the medial preoptic area of the hypothalamus in the rat elicits increases in intracavernous pressure. Neurosci Lett. 1996;209(1):1‐4. DOI: https://doi.org/10.1016/0304-3940(96)12594-5
- McKenna KE. Central control of penile erection. Int J Impot Res. 1998;10 Suppl 1:S25‐S34.
- Andersson KE. Neurophysiology/pharmacology of erection. Int J Impot Res. 2001;13 Suppl 3:S8‐S17. DOI: https://doi.org/10.1038/sj.ijir.3900718
- Opsomer RJ, Boccasena P, Traversa R, Rossini PM. Sympathetic skin responses from the limbs and the genitalia: normative study and contribution to the evaluation of neurourological disorders. Electroencephalogr Clin Neurophysiol. 1996;101(1):25‐31. DOI: https://doi.org/10.1016/0013-4694(95)00168-9
- Valles-Antuña C, Fernandez-Gomez J, Escaf S, Fernandez-Gonzalez F. Sympathetic skin response in patients with erectile dysfunction. BJU Int. 2009;104(11):1709‐1712. DOI: https://doi.org/10.1111/j.1464-410X.2009.08796.x
- Yilmaz U, Soylu A, Ozcan C, Kutlu R, Güneş A. Evoked cavernous activity. J Urol. 2002;167(1):188‐191. DOI: https://doi.org/10.1016/S0022-5347(05)65409-2
- Yang CC, Yilmaz U, Vicars BG. Evoked cavernous activity: normal values. J Urol. 2008;179(6):2312‐2316. DOI: https://doi.org/10.1016/j.juro.2008.01.143
- Jiang XG, Speel TG, Wagner G, Meuleman EJ, Wijkstra H; COST Action B18 project. The value of corpus cavernosum electromyography in erectile dysfunction: current status and future prospect. Eur Urol. 2003;43(3):211‐218. DOI: https://doi.org/10.1016/S0302-2838(03)00011-3
-Chen Y, Tang Y, Vogel LC, Devivo MJ. Causes of spinal cord injury. Top Spinal Cord Inj Rehabil. 2013;19(1):1‐8. DOI: https://doi.org/10.1310/sci1901-1
- Ramos AS, Samsó JV. Specific aspects of erectile dysfunction in spinal cord injury. Int J Impot Res. 2004;16 Suppl 2:S42‐S45. DOI: https://doi.org/10.1038/sj.ijir.3901242
- Hess MJ, Hough S. Impact of spinal cord injury on sexuality: broad-based clinical practice intervention and practical application. J Spinal Cord Med. 2012;35(4):211‐218. DOI: https://doi.org/10.1179/2045772312Y.0000000025
- Albright TH, Grabel Z, DePasse JM, Palumbo MA, Daniels AH. Sexual and Reproductive Function in Spinal Cord Injury and Spinal Surgery Patients. Orthop Rev (Pavia). 2015;7(3):5842. Published 2015 Sep 28. doi:10.4081/or.2015.5842 DOI: https://doi.org/10.4081/or.2015.5842
- Ferro JKO, Lemos A, Silva CPD, et al. Predictive Factors of Male Sexual Dysfunction After Traumatic Spinal Cord Injury. Spine (Phila Pa 1976). 2019;44(17):1228‐1237. DOI: https://doi.org/10.1097/BRS.0000000000003049
- Aikman K, Oliffe JL, Kelly MT, McCuaig F. Sexual Health in Men With Traumatic Spinal Cord Injuries: A Review and Recommendations for Primary Health-Care Providers. Am J Mens Health. 2018;12(6):2044‐2054. DOI: https://doi.org/10.1177/1557988318790883
- Biering-Sørensen F, Sønksen J. Sexual function in spinal cord lesioned men. Spinal Cord. 2001;39(9):455‐470. DOI: https://doi.org/10.1038/sj.sc.3101198
- Khorrami MH, Javid A, Moshtaghi D, Nourimahdavi K, Mortazavi A, Zia HR. Sildenafil efficacy in erectile dysfunction secondary to spinal cord injury depends on the level of cord injuries. Int J Androl. 2010;33(6):861‐864. DOI: https://doi.org/10.1111/j.1365-2605.2009.01033.x
- Derry F, Hultling C, Seftel AD, Sipski ML. Efficacy and safety of sildenafil citrate (Viagra) in men with erectile dysfunction and spinal cord injury: a review. Urology. 2002;60(2 Suppl 2):49‐57. DOI: https://doi.org/10.1016/S0090-4295(02)01690-4
- Ohl DA, Carlsson M, Stecher VJ, Rippon GA. Efficacy and Safety of Sildenafil in Men With Sexual Dysfunction and Spinal Cord Injury. Sex Med Rev. 2017;5(4):521‐528. DOI: https://doi.org/10.1016/j.sxmr.2017.01.007
- Ergin S, Gunduz B, Ugurlu H, et al. A placebo-controlled, multicenter, randomized, double-blind, flexible-dose, two-way crossover study to evaluate the efficacy and safety of sildenafil in men with traumatic spinal cord injury and erectile dysfunction. J Spinal Cord Med. 2008;31(5):522‐531. DOI: https://doi.org/10.1080/10790268.2008.11753647
- Giuliano F, Hultling C, El Masry WS, et al. Randomized trial of sildenafil for the treatment of erectile dysfunction in spinal cord injury. Sildenafil Study Group. Ann Neurol. 1999;46(1):15‐21. DOI: https://doi.org/10.1002/1531-8249(199907)46:1<15::AID-ANA5>3.0.CO;2-U
- Gans WH, Zaslau S, Wheeler S, Galea G, Vapnek JM. Efficacy and safety of oral sildenafil in men with erectile dysfunction and spinal cord injury. J Spinal Cord Med. 2001;24(1):35‐40. DOI: https://doi.org/10.1080/10790268.2001.11753553
- Giuliano F, Sanchez-Ramos A, Löchner-Ernst D, et al. Efficacy and safety of tadalafil in men with erectile dysfunction following spinal cord injury. Arch Neurol. 2007;64(11):1584‐1592. DOI: https://doi.org/10.1001/archneur.64.11.nct70001
- Del Popolo G, Li Marzi V, Mondaini N, Lombardi G. Time/duration effectiveness of sildenafil versus tadalafil in the treatment of erectile dysfunction in male spinal cord-injured patients. Spinal Cord. 2004;42(11):643‐648. DOI: https://doi.org/10.1038/sj.sc.3101617
- Soler JM, Previnaire JG, Denys P, Chartier-Kastler E. Phosphodiesterase inhibitors in the treatment of erectile dysfunction in spinal cord-injured men. Spinal Cord. 2007;45(2):169‐173. DOI: https://doi.org/10.1038/sj.sc.3101950
- Lombardi G, Macchiarella A, Cecconi F, Del Popolo G. Efficacy and safety of medium and long-term tadalafil use in spinal cord patients with erectile dysfunction. J Sex Med. 2009;6(2):535‐543. DOI: https://doi.org/10.1111/j.1743-6109.2008.01106.x
- Sánchez Ramos A, Vidal J, Jáuregui ML, et al. Efficacy, safety and predictive factors of therapeutic success with sildenafil for erectile dysfunction in patients with different spinal cord injuries. Spinal Cord. 2001;39(12):637‐643. DOI: https://doi.org/10.1038/sj.sc.3101210
-Rizio N, Tran C, Sorenson M. Efficacy and satisfaction rates of oral PDE5is in the treatment of erectile dysfunction secondary to spinal cord injury: a review of literature. J Spinal Cord Med. 2012;35(4):219‐228. DOI: https://doi.org/10.1179/2045772312Y.0000000004
- Ethans KD, Casey AR, Schryvers OI, MacNeil BJ. The effects of sildenafil on the cardiovascular response in men with spinal cord injury at or above the sixth thoracic level. J Spinal Cord Med. 2003;26(3):222‐226. DOI: https://doi.org/10.1080/10790268.2003.11753687
- Ethans KD, Casey A, Tarhoni M, Nankar M, Entcheva S. A randomized double-blind, placebo-controlled, cross-over trial assessing the effect of tadalafil (Cialis) on the cardiovascular response in men with complete spinal cord injury above the sixth thoracic level: A Pilot Study. Spinal Cord Ser Cases. 2018;4:105. DOI: https://doi.org/10.1038/s41394-018-0137-9
- Zaslau S, Nicolis C, Galea G, Britanico J, Vapnek JM. A simplified pharmacologic erection program for patients with spinal cord injury. J Spinal Cord Med. 1999;22(4):303‐307. DOI: https://doi.org/10.1080/10790268.1999.11719584
- Kapoor VK, Chahal AS, Jyoti SP, Mundkur YJ, Kotwal SV, Mehta VK. Intracavernous papaverine for impotence in spinal cord injured patients. Paraplegia. 1993;31(10):675‐677. DOI: https://doi.org/10.1038/sc.1993.108
- Wyndaele JJ, de Meyer JM, de Sy WA, Claessens H. Intracavernous injection of vasoactive drugs, an alternative for treating impotence in spinal cord injury patients. Paraplegia. 1986;24(5):271‐275. DOI: https://doi.org/10.1038/sc.1986.37
- Bodner DR, Haas CA, Krueger B, Seftel AD. Intraurethral alprostadil for treatment of erectile dysfunction in patients with spinal cord injury. Urology. 1999;53(1):199‐202. DOI: https://doi.org/10.1016/S0090-4295(98)00435-X
- Lebib Ben Achour S, Laffont I, Boyer F, Boiteau F, Dizien O. Utilisation des injections intracaverneuses dans les dysfonctionnements érectiles du blessé médullaire : à propos d'une expérience sur 36 patients [Intracavernous injections in the treatment of erectile dysfunction in spinal cord injured patients: experience with 36 patients]. Ann Readapt Med Phys. 2001;44(1):35‐40. [Article in French]. DOI: https://doi.org/10.1016/S0168-6054(00)00061-1
- Tang SF, Chu NK, Wong MK. Intracavernous injection of prostaglandin E1 in spinal cord injured patients with erectile dysfunction. A preliminary report. Paraplegia. 1995;33(12):731‐733. DOI: https://doi.org/10.1038/sc.1995.153
-Hirsch IH, Smith RL, Chancellor MB, Bagley DH, Carsello J, Staas WE Jr. Use of intracavernous injection of prostaglandin E1 for neuropathic erectile dysfunction. Paraplegia. 1994;32(10):661‐664. DOI: https://doi.org/10.1038/sc.1994.106
- Earle CM, Keogh EJ, Ker JK, Cherry DJ, Tulloch AG, Lord DJ. The role of intracavernosal vasoactive agents to overcome impotence due to spinal cord injury. Paraplegia. 1992;30(4):273‐276. DOI: https://doi.org/10.1038/sc.1992.68
- Sidi AA, Cameron JS, Dykstra DD, Reinberg Y, Lange PH. Vasoactive intracavernous pharmacotherapy for the treatment of erectile impotence in men with spinal cord injury. J Urol. 1987;138(3):539‐542. DOI: https://doi.org/10.1016/S0022-5347(17)43252-6
-Beretta G, Zanollo A, Fanciullacci F, Catanzaro F. Intracavernous injection of papaverine in paraplegic males. Acta Eur Fertil. 1986;17(4):283‐284.
- Sønksen JO, Hansen EF, Biering-Sørensen F, Colstrup H. Intrakavernøs selvinjektion til behandling af erektiv dysfunktion hos rygmarvsskadede [Intracavernous self-injection for treatment of erectile dysfunction inpatients with spinal cord injuries]. Ugeskr Laeger. 1990;152(41):3006‐3009.
- Momose H, Natsume O, Yamamoto M, Suemori T, Yamada K. Hinyokika Kiyo. 1987;33(7):1065‐1069.
- Denil J, Ohl DA, Smythe C. Vacuum erection device in spinal cord injured men: patient and partner satisfaction. Arch Phys Med Rehabil. 1996;77(8):750‐753. DOI: https://doi.org/10.1016/S0003-9993(96)90252-X
- Seckin B, Atmaca I, Ozgok Y, Gokalp A, Harmankaya C. External vacuum device therapy for spinal cord injured males with erectile dysfunction. Int Urol Nephrol. 1996;28(2):235‐240. DOI: https://doi.org/10.1007/BF02550868
- Rivas DA, Chancellor MB. Complications associated with the use of vacuum constriction devices for erectile dysfunction in the spinal cord injured population. J Am Paraplegia Soc. 1994;17(3):136‐139. DOI: https://doi.org/10.1080/01952307.1994.11735923
- Mulcahy JJ, Austoni E, Barada JH, et al. The penile implant for erectile dysfunction [published correction appears in J Sex Med. 2006 Sep;3(5):938. Hellstrom, Wayne JG [corrected to Hellstrom, WJ]; Shultheiss, Dirk [corrected to Schultheiss, Dirk]]. J Sex Med. 2004;1(1):98‐109.
- Kim YD, Yang SO, Lee JK, Jung TY, Shim HB. Usefulness of a malleable penile prosthesis in patients with a spinal cord injury. Int J Urol. 2008;15(10):919‐923. DOI: https://doi.org/10.1111/j.1442-2042.2008.02115.x
- Iwatsubo E, Tanaka M, Takahashi K, Akatsu T. Non-inflatable penile prosthesis for the management of urinary incontinence and sexual disability of patients with spinal cord injury. Paraplegia. 1986;24(5):307‐310. DOI: https://doi.org/10.1038/sc.1986.43
-Green BG, Sloan SL. Penile prostheses in spinal cord injured patients: combined psychosexual counselling and surgical regimen. Paraplegia. 1986;24(3):167‐172. DOI: https://doi.org/10.1038/sc.1986.22
- Gross AJ, Sauerwein DH, Kutzenberger J, Ringert RH. Penile prostheses in paraplegic men. Br J Urol. 1996;78(2):262‐264. DOI: https://doi.org/10.1046/j.1464-410X.1996.08021.x
- Moemen MN, Fahmy I, AbdelAal M, Kamel I, Mansour M, Arafa MM. Erectile dysfunction in spinal cord-injured men: different treatment options. Int J Impot Res. 2008;20(2):181‐187. DOI: https://doi.org/10.1038/sj.ijir.3901600
- Linsenmeyer TA. Treatment of erectile dysfunction following spinal cord injury. Curr Urol Rep. 2009;10(6):478‐484. DOI: https://doi.org/10.1007/s11934-009-0076-x
- Martens FM, Heesakkers JP. Clinical results of a brindley procedure: sacral anterior root stimulation in combination with a rhizotomy of the dorsal roots. Adv Urol. 2011;2011:709708. DOI: https://doi.org/10.1155/2011/709708
- Lombardi G, Musco S, Kessler TM, Li Marzi V, Lanciotti M, Del Popolo G. Management of sexual dysfunction due to central nervous system disorders: a systematic review. BJU Int. 2015;115 Suppl 6:47‐56. DOI: https://doi.org/10.1111/bju.13055
-Korpelainen JT, Kauhanen ML, Kemola H, Malinen U, Myllylä VV. Sexual dysfunction in stroke patients. Acta Neurol Scand. 1998;98(6):400‐405. DOI: https://doi.org/10.1111/j.1600-0404.1998.tb07321.x
-Dai H, Wang J, Zhao Q, et al. Erectile dysfunction and associated risk factors in male patients with ischemic stroke: A cross-sectional study. Medicine (Baltimore). 2020;99(1):e18583. DOI: https://doi.org/10.1097/MD.0000000000018583
-Winder K, Seifert F, Köhrmann M, et al. Lesion mapping of stroke-related erectile dysfunction. Brain. 2017;140(6):1706‐1717. DOI: https://doi.org/10.1093/brain/awx080
-Jung JH, Kam SC, Choi SM, Jae SU, Lee SH, Hyun JS. Sexual dysfunction in male stroke patients: correlation between brain lesions and sexual function. Urology. 2008;71(1):99‐103. DOI: https://doi.org/10.1016/j.urology.2007.08.045
-Coslett HB, Heilman KM. Male sexual function. Impairment after right hemisphere stroke. Arch Neurol. 1986;43(10):1036‐1039. DOI: https://doi.org/10.1001/archneur.1986.00520100048013
-Sikiru L, Shmaila H, Yusuf GS. Erectile dysfunction in older male stroke patients: correlation between side of hemiplegia and erectile function. Afr J Reprod Health. 2009;13(2):49‐54.
-Choi-Kwon S, Kim JS. Poststroke emotional incontinence and decreased sexual activity. Cerebrovasc Dis. 2002;13(1):31‐37. DOI: https://doi.org/10.1159/000047743
- Calabrò RS, Gervasi G, Bramanti P. Male sexual disorders following stroke: an overview. Int J Neurosci. 2011;121(11):598‐604. DOI: https://doi.org/10.3109/00207454.2011.600647
- Rosenbaum T, Vadas D, Kalichman L. Sexual function in post-stroke patients: considerations for rehabilitation. J Sex Med. 2014;11(1):15‐21. DOI: https://doi.org/10.1111/jsm.12343
- Grenier-Genest A, Gérard M, Courtois F. Stroke and sexual functioning: A literature review. NeuroRehabilitation. 2017;41(2):293‐315. DOI: https://doi.org/10.3233/NRE-001481
- Stein J, Hillinger M, Clancy C, Bishop L. Sexuality after stroke: patient counseling preferences. Disabil Rehabil. 2013;35(21):1842‐1847. DOI: https://doi.org/10.3109/09638288.2012.754953
- Ng L, Sansom J, Zhang N, Amatya B, Khan F. Effectiveness of a structured sexual rehabilitation programme following stroke: A randomized controlled trial. J Rehabil Med. 2017;49(4):333‐340. DOI: https://doi.org/10.2340/16501977-2219
- Tibaek S, Gard G, Dehlendorff C, et al. The effect of pelvic floor muscle training on sexual function in men with lower urinary tract symptoms after stroke. Top Stroke Rehabil. 2015;22(3):185‐193. DOI: https://doi.org/10.1179/1074935714Z.0000000019
- Calabrò RS, Bramanti P. Post-stroke sexual dysfunction: an overlooked and under-addressed problem. Disabil Rehabil. 2014;36(3):263‐264. DOI: https://doi.org/10.3109/09638288.2013.785603
- Ölmestig JNE, Marlet IR, Hainsworth AH, Kruuse C. Phosphodiesterase 5 inhibition as a therapeutic target for ischemic stroke: A systematic review of preclinical studies. Cell Signal. 2017;38:39‐48. DOI: https://doi.org/10.1016/j.cellsig.2017.06.015
-Beitz JM. Parkinson's disease: a review. Front Biosci (Schol Ed). 2014;6:65‐74. DOI: https://doi.org/10.2741/S415
-Meco G, Rubino A, Caravona N, Valente M. Sexual dysfunction in Parkinson's disease. Parkinsonism Relat Disord. 2008;14(6):451‐456. DOI: https://doi.org/10.1016/j.parkreldis.2007.10.008
-Gao X, Chen H, Schwarzschild MA, et al. Erectile function and risk of Parkinson's disease. Am J Epidemiol. 2007;166(12):1446‐1450. DOI: https://doi.org/10.1093/aje/kwm246
-Sakakibara R, Kishi M, Ogawa E, et al. Bladder, bowel, and sexual dysfunction in Parkinson's disease. Parkinsons Dis. 2011;2011:924605. DOI: https://doi.org/10.4061/2011/924605
-Yang Y, Liu H, Lin T, Kuo Y, Hsieh T. Relationship between Erectile Dysfunction, Comorbidity, and Parkinson's Disease: Evidence from a Population-Based Longitudinal Study. J Clin Neurol. 2017;13(3):250‐258. DOI: https://doi.org/10.3988/jcn.2017.13.3.250
-Codling D, Shaw P, David AS. Hypersexuality in Parkinson's Disease: Systematic Review and Report of 7 New Cases. Mov Disord Clin Pract. 2015;2(2):116‐126. DOI: https://doi.org/10.1002/mdc3.12155
-Zesiewicz TA, Sullivan KL, Arnulf I, et al. Practice Parameter: treatment of nonmotor symptoms of Parkinson disease: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2010;74(11):924‐931. DOI: https://doi.org/10.1212/WNL.0b013e3181d55f24
- Raffaele R, Vecchio I, Giammusso B, Morgia G, Brunetto MB, Rampello L. Efficacy and safety of fixed-dose oral sildenafil in the treatment of sexual dysfunction in depressed patients with idiopathic Parkinson's disease. Eur Urol. 2002;41(4):382‐386. DOI: https://doi.org/10.1016/S0302-2838(02)00054-4
- Zesiewicz TA, Helal M, Hauser RA. Sildenafil citrate (Viagra) for the treatment of erectile dysfunction in men with Parkinson's disease. Mov Disord. 2000;15(2):305‐308. DOI: https://doi.org/10.1002/1531-8257(200003)15:2<305::AID-MDS1015>3.0.CO;2-W
- Bernard BA, Metman LV, Levine L, Ouyang B, Leurgans S, Goetz CG. Sildenafil in the Treatment of Erectile Dysfunction in Parkinson's Disease. Mov Disord Clin Pract. 2016;4(3):412‐415. DOI: https://doi.org/10.1002/mdc3.12456
- Hussain IF, Brady CM, Swinn MJ, Mathias CJ, Fowler CJ. Treatment of erectile dysfunction with sildenafil citrate (Viagra) in parkinsonism due to Parkinson's disease or multiple system atrophy with observations on orthostatic hypotension. J Neurol Neurosurg Psychiatry. 2001;71(3):371‐374. DOI: https://doi.org/10.1136/jnnp.71.3.371
- Carbone F, Djamshidian A, Seppi K, Poewe W. Apomorphine for Parkinson's Disease: Efficacy and Safety of Current and New Formulations. CNS Drugs. 2019;33(9):905‐918. DOI: https://doi.org/10.1007/s40263-019-00661-z
- O'Sullivan JD, Hughes AJ. Apomorphine-induced penile erections in Parkinson's disease. Mov Disord. 1998;13(3):536‐539. DOI: https://doi.org/10.1002/mds.870130326
- Heaton JP, Morales A, Adams MA, Johnston B, el-Rashidy R. Recovery of erectile function by the oral administration of apomorphine. Urology. 1995;45(2):200‐206. DOI: https://doi.org/10.1016/0090-4295(95)80005-0
- Blute M, Hakimian P, Kashanian J, Shteynshluyger A, Lee M, Shabsigh R. Erectile dysfunction and testosterone deficiency. Front Horm Res. 2009;37:108‐122. DOI: https://doi.org/10.1159/000176048
- Okun MS, Walter BL, McDonald WM, et al. Beneficial effects of testosterone replacement for the nonmotor symptoms of Parkinson disease. Arch Neurol. 2002;59(11):1750‐1753. DOI: https://doi.org/10.1001/archneur.59.11.1750
- Okun MS, Fernandez HH, Rodriguez RL, et al. Testosterone therapy in men with Parkinson disease: results of the TEST-PD Study. Arch Neurol. 2006;63(5):729‐735. DOI: https://doi.org/10.1001/archneur.63.5.729
- Pohanka M, Kanovský P, Bares M, Pulkrábek J, Rektor I. Pergolide mesylate can improve sexual dysfunction in patients with Parkinson's disease: the results of an open, prospective, 6-month follow-up. Eur J Neurol. 2004;11(7):483‐488. DOI: https://doi.org/10.1111/j.1468-1331.2004.00820.x
- van Hees PJ, van der Plas AA, van Ek GF, et al. Discussing sexuality with patients with Parkinson's disease: a survey among Dutch neurologists. J Neural Transm (Vienna). 2017;124(3):361‐368. DOI: https://doi.org/10.1007/s00702-016-1655-x
- Balsamo R, Arcaniolo D, Stizzo M, et al. Increased risk of erectile dysfunction in men with multiple sclerosis: an Italian cross-sectional study. Cent European J Urol. 2017;70(3):289‐295.
- Guo ZN, He SY, Zhang HL, Wu J, Yang Y. Multiple sclerosis and sexual dysfunction. Asian J Androl. 2012;14(4):530‐535. DOI: https://doi.org/10.1038/aja.2011.110
- Landtblom AM. Treatment of erectile dysfunction in multiple sclerosis. Expert Rev Neurother. 2006;6(6):931‐935. DOI: https://doi.org/10.1586/14737175.6.6.931
- Fowler CJ, Miller JR, Sharief MK, Hussain IF, Stecher VJ, Sweeney M. A double blind, randomised study of sildenafil citrate for erectile dysfunction in men with multiple sclerosis. J Neurol Neurosurg Psychiatry. 2005;76(5):700‐705. DOI: https://doi.org/10.1136/jnnp.2004.038695
- Safarinejad MR. Evaluation of the safety and efficacy of sildenafil citrate for erectile dysfunction in men with multiple sclerosis: a double-blind, placebo controlled, randomized study. J Urol. 2009;181(1):252‐258. DOI: https://doi.org/10.1016/j.juro.2008.09.003
- Lombardi G, Macchiarella A, Del Popolo G. Efficacy and safety of tadalafil for erectile dysfunction in patients with multiple sclerosis. J Sex Med. 2010;7(6):2192‐2200. DOI: https://doi.org/10.1111/j.1743-6109.2010.01797.x
- Vidal J, Curcoll L, Roig T, Bagunyá J. Intracavernous pharmacotherapy for management of erectile dysfunction in multiple sclerosis patients. Rev Neurol. 1995;23(120):269‐271.
- Kirkeby HJ, Petersen T, Poulsen EU. Pharmacologically induced erection in patients with multiple sclerosis. Scand J Urol Nephrol. 1988;22(4):241‐244. DOI: https://doi.org/10.3109/00365598809180793
- Hirsch IH, Smith RL, Chancellor MB, Bagley DH, Carsello J, Staas WE Jr. Use of intracavernous injection of prostaglandin E1 for neuropathic erectile dysfunction. Paraplegia. 1994;32(10):661‐664. DOI: https://doi.org/10.1038/sc.1994.106
- Foley FW, LaRocca NG, Sanders AS, Zemon V. Rehabilitation of intimacy and sexual dysfunction in couples with multiple sclerosis. Mult Scler. 2001;7(6):417‐421. DOI: https://doi.org/10.1177/135245850100700612
-Rathore C, Henning OJ, Luef G, Radhakrishnan K. Sexual dysfunction in people with epilepsy. Epilepsy Behav. 2019;100(Pt A):106495. DOI: https://doi.org/10.1016/j.yebeh.2019.106495
-Montouris G, Morris GL 3rd. Reproductive and sexual dysfunction in men with epilepsy. Epilepsy Behav. 2005;7 Suppl 2:S7‐S14. DOI: https://doi.org/10.1016/j.yebeh.2005.08.026
-Smaldone M, Sukkarieh T, Reda A, Khan A. Epilepsy and erectile dysfunction: a review. Seizure. 2004;13(7):453‐459. DOI: https://doi.org/10.1016/j.seizure.2003.12.006
-Daniele A, Azzoni A, Bizzi A, Rossi A, Gainotti G, Mazza S. Sexual behavior and hemispheric laterality of the focus in patients with temporal lobe epilepsy. Biol Psychiatry. 1997;42(7):617‐624. DOI: https://doi.org/10.1016/S0006-3223(96)00411-8
- Harden CL. Sexuality in men and women with epilepsy. CNS Spectr. 2006;11(8 Suppl 9):13‐18. DOI: https://doi.org/10.1017/S1092852900026717
- Bauer J, Stoffel-Wagner B, Flügel D, et al. Serum androgens return to normal after temporal lobe epilepsy surgery in men. Neurology. 2000;55(6):820‐824. DOI: https://doi.org/10.1212/WNL.55.6.820
- Spark RF, Wills CA, Royal H. Hypogonadism, hyperprolactinaemia, and temporal lobe epilepsy in hyposexual men. Lancet. 1984;1(8374):413‐417. DOI: https://doi.org/10.1016/S0140-6736(84)91751-3
- Najafi MR, Ansari B, Zare M, Fatehi F, Sonbolestan A. Effects of antiepileptic drugs on sexual function and reproductive hormones of male epileptic patients. Iran J Neurol. 2012;11(2):37‐41.
- Yogarajah M, Mula M. Sexual Dysfunction in Epilepsy and the Role of Anti-Epileptic Drugs. Curr Pharm Des. 2017;23(37):5649‐5661. DOI: https://doi.org/10.2174/1381612823666171004115230
- Yogarajah M, Mula M. Sexual Dysfunction in Epilepsy and the Role of Anti-Epileptic Drugs. Curr Pharm Des. 2017;23(37):5649‐5661. DOI: https://doi.org/10.2174/1381612823666171004115230
-Sachdeo R, Sathyan RR. Amelioration of erectile dysfunction following a switch from carbamazepine to oxcarbazepine: recent clinical experience. Curr Med Res Opin. 2005;21(7):1065‐1068. DOI: https://doi.org/10.1185/030079905X50561
- Alhathal N, Elshal AM, Carrier S. Synergetic effect of testosterone and phophodiesterase-5 inhibitors in hypogonadal men with erectile dysfunction: A systematic review. Can Urol Assoc J. 2012;6(4):269‐274. DOI: https://doi.org/10.5489/cuaj.11291
- Talbot JA, Sheldrick R, Caswell H, Duncan S. Sexual function in men with epilepsy: how important is testosterone?. Neurology. 2008;70(16):1346‐1352. DOI: https://doi.org/10.1212/01.wnl.0000311242.51618.b7
- Bóné B, Janszky J. Az epilepszia es a férfi nemi muködes zavara: okok, diagnózis es terápia [Epilepsy and male sexual dysfunction: etiology, diagnosis and therapy]. Ideggyogy Sz. 2006;59(5-6):148‐152.
- Matos G, Scorza FA, Cavalheiro EA, Tufik S, Andersen ML. PDEI-5 for erectile dysfunction: a potential role in seizure susceptibility. J Sex Med. 2012;9(8):2111‐2121. DOI: https://doi.org/10.1111/j.1743-6109.2012.02780.x
- Riazi K, Roshanpour M, Rafiei-Tabatabaei N, Homayoun H, Ebrahimi F, Dehpour AR. The proconvulsant effect of sildenafil in mice: role of nitric oxide-cGMP pathway. Br J Pharmacol. 2006;147(8):935‐943. DOI: https://doi.org/10.1038/sj.bjp.0706680
- Socała K, Nieoczym D, Pieróg M, et al. Effect of Tadalafil on Seizure Threshold and Activity of Antiepileptic Drugs in Three Acute Seizure Tests in Mice. Neurotox Res. 2018;34(3):333‐346. DOI: https://doi.org/10.1007/s12640-018-9876-4
- Braun M, Sommer F, Lehmacher W, Raible A, Bondarenko B, Engelmann U. [Erectile dysfunction. Are interdisciplinary diagnosis and therapy necessary?]. Dtsch Med Wochenschr. 2004 ;129(4):131-6.
- Akbaş NB, Dalbayrak S, Külcü DG, Yilmaz M, Yilmaz T, Naderi S. Assessment of sexual dysfunction before and after surgery for lumbar disc herniation. J Neurosurg Spine. 2010;13(5):581-6. DOI: https://doi.org/10.3171/2010.5.SPINE09906
- Kanayama M, Horio M, Umi Y, et al. How does surgery affect sexual desire and activities in patients with lumbar disc herniation? Spine (Phila Pa 1976). 2010;35(6):647-51. DOI: https://doi.org/10.1097/BRS.0b013e3181ba29f9
- Yazici CM, Sarifakioglu B, Guzelant A, Turker P, Ates O. An unresolved discussion: presence of premature ejaculation and erectile dysfunction in lumbar disc hernia. Int Urol Nephrol. 2013 ;45(3):659-67. DOI: https://doi.org/10.1007/s11255-013-0411-5
- Akca N, Ozdemir B, Kanat A, Batcik OE, Yazar U, Zorba OU. Describing a new syndrome in L5-S1 disc herniation: Sexual and sphincter dysfunction without pain and muscle weakness. J Craniovertebr Junction Spine. 2014;5(4):146‐150. DOI: https://doi.org/10.4103/0974-8237.147076
-Xu HD, Zhao JN, Xu B, Liu G, He HW. [Penile erectile function after lumbar discectomy for intervertebral disc herniation in different age groups of male patients]. Zhonghua Nan Ke Xue. 2013;19(7):626-9.
- Dzierżanowski M, Dzierżanowski M, Wrzecion K, et al. Discopathy of the lumbar-sacral segment and its influence on sexual dysfunction. Adv Clin Exp Med. 2013;22(1):93-100.
- Podnar S, Oblak C, Vodusek DB. Sexual function in men with cauda equina lesions: a clinical and electromyographic study. J Neurol Neurosurg Psychiatry. 2002;73(6):715‐720. DOI: https://doi.org/10.1136/jnnp.73.6.715
-DS. Early relief of erectile dysfunction after laser decompression of herniated lumbar disc. J Clin Laser Med Surg. 1999;17(1):25-7. DOI: https://doi.org/10.1089/clm.1999.17.25
- Orlin JR, Klevmark B. Successful disc surgery after 17 years of erectile dysfunction caused by a "silent" disc protrusion. Scand J Urol Nephrol. 2008;42(1):91-3. DOI: https://doi.org/10.1080/00365590701428467
- Kulaksizoglu H, Kaptan H. An unappreciated correlation : surgical treatment of lumbosacral disc disease and erectile dysfunction. J Korean Neurosurg Soc. 2010;47(4):282-6. DOI: https://doi.org/10.3340/jkns.2010.47.4.282
- Stefanova N, Bücke P, Duerr S, Wenning GK. Multiple system atrophy: an update. Lancet Neurol. 2009;8(12):1172-8. DOI: https://doi.org/10.1016/S1474-4422(09)70288-1
- Kirchhof K, Apostolidis AN, Mathias CJ, Fowler CJ. Erectile and urinary dysfunction may be the presenting features in patients with multiple system atrophy: a retrospective study. Int J Impot Res. 2003;15(4):293-8. DOI: https://doi.org/10.1038/sj.ijir.3901014
- Papatsoris AG, Papapetropoulos S, Singer C, Deliveliotis C. Urinary and erectile dysfunction in multiple system atrophy (MSA). Neurourol Urodyn. 2008;27(1):22-7. DOI: https://doi.org/10.1002/nau.20461
- Palma JA, Kaufmann H. Treatment of autonomic dysfunction in Parkinson disease and other synucleinopathies. Mov Disord. 2018;33(3):372‐390. DOI: https://doi.org/10.1002/mds.27344
- Podnar S, Vodušek DB. Sexual dysfunction in patients with peripheral nervous system lesions. Handb Clin Neurol. 2015;130:179-202. DOI: https://doi.org/10.1016/B978-0-444-63247-0.00011-0
- Furukawa S, Sakai T, Niiya T, et al. Diabetic peripheral neuropathy and prevalence of erectile dysfunction in Japanese patients aged <65 years with type 2 diabetes mellitus: The Dogo Study. Int J Impot Res. 2017;29(1):30-34. DOI: https://doi.org/10.1038/ijir.2016.40
- Maiorino MI, Bellastella G, Esposito K. Diabetes and sexual dysfunction: current perspectives. Diabetes Metab Syndr Obes. 2014;7:95‐105. DOI: https://doi.org/10.2147/DMSO.S36455
- Benvenuti F, Boncinelli L, Vignoli GC. Male sexual impotence in diabetes mellitus: vasculogenic versus neurogenic factors. Neurourol Urodyn. 1993;12(2):145-51; discussion 152. DOI: https://doi.org/10.1002/nau.1930120208
- Hecht MJ, Neundörfer B, Kiesewetter F, Hilz MJ. Neuropathy is a major contributing factor to diabetic erectile dysfunction. Neurol Res. 2001;23(6):651-4. DOI: https://doi.org/10.1179/016164101101198965
- Cellek S, Cameron NE, Cotter MA, Muneer A. Pathophysiology of diabetic erectile dysfunction: potential contribution of vasa nervorum and advanced glycation endproducts. Int J Impot Res. 2013;25(1):1-6. DOI: https://doi.org/10.1038/ijir.2012.30
- Tamás V, Kempler P. Sexual dysfunction in diabetes. Handb Clin Neurol. 2014;126:223-32. DOI: https://doi.org/10.1016/B978-0-444-53480-4.00017-5
- Yoshimura N, Kato R, Chancellor MB, Nelson JB, Glorioso JC. Gene therapy as future treatment of erectile dysfunction. Expert Opin Biol Ther. 2010;10(9):1305‐1314. DOI: https://doi.org/10.1517/14712598.2010.510510
- Burnett AL. Erectile function outcomes in the current era of anatomic nerve-sparing radical prostatectomy. Rev Urol. 2006;8(2):47‐53.
- Padma-Nathan H, McCullough A, Forest C. Erectile dysfunction secondary to nerve-sparing radical retropubic prostatectomy: comparative phosphodiesterase-5 inhibitor efficacy for therapy and novel prevention strategies. Curr Urol Rep. 2004;5(6):467-71. DOI: https://doi.org/10.1007/s11934-004-0072-0
- Capogrosso P, Salonia A, Briganti A, Montorsi F. Postprostatectomy Erectile Dysfunction: A Review. World J Mens Health. 2016;34(2):73-88. DOI: https://doi.org/10.5534/wjmh.2016.34.2.73

How to Cite

Moussa, M., Papatsoris, A. G. ., Abou Chakra, M., Dabboucy, B., & Fares, Y. (2020). Erectile dysfunction in common neurological conditions: A narrative review. Archivio Italiano Di Urologia E Andrologia, 92(4). https://doi.org/10.4081/aiua.2020.4.371

PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.